Quanterix to Showcase Innovations at Goldman Sachs Global Healthcare Conference
Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Businesswire
Image: Businesswire
Quanterix Corporation, a leader in biomarker detection, will participate in the Goldman Sachs 47th Annual Global Healthcare Conference from June 8-10, 2026, in Miami, Florida. CEO Everett Cunningham will discuss the company's strategic priorities during a fireside chat on June 9.
- 01Quanterix Corporation is known for its Simoa® technology, which allows for ultra-sensitive biomarker detection.
- 02The company has approximately 6,500 peer-reviewed publications, highlighting its significant contributions to the scientific community.
- 03Quanterix acquired Akoya Biosciences in 2025, enhancing its capabilities in multiplexed tissue imaging.
- 04The conference will feature one-on-one investor meetings in addition to the CEO's presentation.
- 05The live webcast of the presentation will be accessible on Quanterix's Investor Relations website.
Advertisement
In-Article Ad
Quanterix Corporation (Nasdaq: QTRX), based in Billerica, Massachusetts, will participate in the Goldman Sachs 47th Annual Global Healthcare Conference scheduled for June 8-10, 2026, in Miami, Florida. During the event, CEO Everett Cunningham will host a fireside chat on June 9 at 1:20 pm ET, where he will discuss the company's latest updates and strategic priorities. Quanterix is recognized for its pioneering Simoa® technology, which enables the detection of biomarkers in blood and other fluids at unprecedented sensitivity levels. With around 6,500 peer-reviewed publications, the company has established itself as a key player in disease research and diagnostics. In 2025, Quanterix expanded its offerings by acquiring Akoya Biosciences, which specializes in multiplexed tissue imaging, thereby enhancing its integrated platform for advancing precision medicine. Investors can access the live webcast of the presentation through the company's Investor Relations section, with a replay available afterward.
Advertisement
In-Article Ad
Advertisement
In-Article Ad
Reader Poll
What do you think about the advancements in biomarker detection technology?
Connecting to poll...
Read the original article
Visit the source for the complete story.




